Home
MRK
MRK News

Latest Merck & Company Inc. (new) (MRK) News on July 16, 2025

Adagene Announces Regulatory Update on Clinical Development Plan for Muzastotug in Microsatellite Stable Colorectal Cancer Following Productive Type B (End of Phase 1) Meeting with FDA

GlobeNewswire

15 hours ago

Adagene Announces Regulatory Update on Clinical Development Plan for Muzastotug in Microsatellite Stable Colorectal Cancer Following Productive Type B (End of Phase 1) Meeting with FDA

Merck (NYSE:MRK) Partners With Gates Foundation For HIV PrEP Trials In 16 Countries

Simply Wall St.

a day ago

Merck (NYSE:MRK) Partners With Gates Foundation For HIV PrEP Trials In 16 Countries

Merck to Acquire Verona for $10 Billion, Targeting Life Beyond Keytruda

GuruFocus.com

a day ago

Merck to Acquire Verona for $10 Billion, Targeting Life Beyond Keytruda

The Zacks Analyst Blog Highlights Microsoft, Alibaba Group, Merck, Monarch Cement and Team

Zacks

a day ago

The Zacks Analyst Blog Highlights Microsoft, Alibaba Group, Merck, Monarch Cement and Team

MRK's Buyout Spree to Broaden Product Portfolio: Can it Aid Growth?

Zacks

a day ago

MRK's Buyout Spree to Broaden Product Portfolio: Can it Aid Growth?

MT Newswires

2 days ago

Merck to Start Phase 3 Trials of MK-8527 for HIV Prevention

Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill

Business Wire

2 days ago

Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill

HER2+ Gastric Cancer Market Analysis and Forecast Report 2025-2035: AstraZeneca, Merck, and Roche Lead Innovation in HER2+ Gastric Cancer Therapies

GlobeNewswire

2 days ago

HER2+ Gastric Cancer Market Analysis and Forecast Report 2025-2035: AstraZeneca, Merck, and Roche Lead Innovation in HER2+ Gastric Cancer Therapies

Biotech Stocks Are Ready to Rebound. 3 to Watch Now.

Barrons.com

2 days ago

Biotech Stocks Are Ready to Rebound. 3 to Watch Now.

China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline

Bloomberg

2 days ago

China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline

Trump Says 200% Pharma Tariffs Are Coming. Wall Street Shrugs.

The Wall Street Journal

3 days ago

Trump Says 200% Pharma Tariffs Are Coming. Wall Street Shrugs.

Investing.com

3 days ago

Will Trump’s 200% tariff threat on pharma really materialize?

Merck & Co., Inc. (MRK)’s CEO Thinks He’s Got $50 Billion Of New Drugs, Says Jim Cramer

Insider Monkey

3 days ago

Merck & Co., Inc. (MRK)’s CEO Thinks He’s Got $50 Billion Of New Drugs, Says Jim Cramer

Verona Pharma plc (VRNA): Jim Cramer Approves The Merck Acquisition

Insider Monkey

3 days ago

Verona Pharma plc (VRNA): Jim Cramer Approves The Merck Acquisition

FDA willing to trade faster drug reviews for lower prices, Bloomberg reports

TipRanks

4 days ago

FDA willing to trade faster drug reviews for lower prices, Bloomberg reports

Morningstar Research

4 days ago

Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover

Big pharma's multiple looming patent cliffs: What to know

Yahoo Finance Video

4 days ago

Big pharma's multiple looming patent cliffs: What to know

Top Analyst Reports for Microsoft, Alibaba & Merck

Zacks

4 days ago

Top Analyst Reports for Microsoft, Alibaba & Merck

FDA Accepts Merck's Filing for Two-Drug, Once-Daily HIV Pill

Zacks

4 days ago

FDA Accepts Merck's Filing for Two-Drug, Once-Daily HIV Pill

MRUS Stock Soars 30% in 3 Months After Phase II Cancer Study Success

Zacks

4 days ago

MRUS Stock Soars 30% in 3 Months After Phase II Cancer Study Success

MT Newswires

5 days ago

Jefferies Adjusts Merck & Co.'s Price Target to $141 From $138, Keeps Buy Rating

Merck's VRNA Buyout to Add Novel COPD Therapy: How to Play the Stock?

Zacks

5 days ago

Merck's VRNA Buyout to Add Novel COPD Therapy: How to Play the Stock?

2 Top Stocks Down 16% and 17% This Year to Buy and Hold

Motley Fool

5 days ago

2 Top Stocks Down 16% and 17% This Year to Buy and Hold

MT Newswires

5 days ago

Merck Animal Health Gets FDA Approval for Bravecto Quantum

FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health

Business Wire

5 days ago

FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health

Pod Digital Media Celebrates Seven Years of Connecting Brands Authentically to Growth Audiences

Business Wire

5 days ago

Pod Digital Media Celebrates Seven Years of Connecting Brands Authentically to Growth Audiences

Veteran analyst sends bold message on Palantir stock target

TheStreet

5 days ago

Veteran analyst sends bold message on Palantir stock target

MT Newswires

5 days ago

Morgan Stanley Adjusts Price Target on Merck to $98 From $99, Maintains Equalweight Rating

Alcohol Related Liver Disease Market Forecast, 2025-2035 | Personalized Medicine Transforming ARLD Treatment Landscape

GlobeNewswire

6 days ago

Alcohol Related Liver Disease Market Forecast, 2025-2035 | Personalized Medicine Transforming ARLD Treatment Landscape

Verona Pharma (VRNA) Skyrockets 20.6% on $10-Billion Merger Deal with Merck

Insider Monkey

6 days ago

Verona Pharma (VRNA) Skyrockets 20.6% on $10-Billion Merger Deal with Merck

MT Newswires

6 days ago

Merck Says FDA Accepts for Review New Drug Application for Doravirine/Islatravir to Treat HIV-1 Infection in Adults

Trump Says Powell’s Fed Job Is Easy. Why Nvidia, Bitcoin, Market Rally Say Otherwise and 5 Other Things to Know Today.

Barrons.com

6 days ago

Trump Says Powell’s Fed Job Is Easy. Why Nvidia, Bitcoin, Market Rally Say Otherwise and 5 Other Things to Know Today.

U.S. FDA Accepts New Drug Application for Merck’s Doravirine/Islatravir, an Investigational, Once-Daily, Oral, Two-Drug Regimen for Treatment of Adults with Virologically Suppressed HIV-1 Infection

Business Wire

6 days ago

U.S. FDA Accepts New Drug Application for Merck’s Doravirine/Islatravir, an Investigational, Once-Daily, Oral, Two-Drug Regimen for Treatment of Adults with Virologically Suppressed HIV-1 Infection

Pharmaceutical Technology

6 days ago

Merck agrees to acquire Verona Pharma for $10bn

Zacks Investment Ideas feature highlights: QQQ, IWM, SBET, CRCL, COIN, AES, MRK and VRNA

Zacks

6 days ago

Zacks Investment Ideas feature highlights: QQQ, IWM, SBET, CRCL, COIN, AES, MRK and VRNA

Podcast: Trump Sends More Tariff Letters; Nasdaq Climbs to Record

The Wall Street Journal

6 days ago

Podcast: Trump Sends More Tariff Letters; Nasdaq Climbs to Record

Stock Market Today: Dow Jones Index Rises Ahead Of Fed Minutes; Nvidia Hits New High (Live Coverage)

Investor's Business Daily

7 days ago

Stock Market Today: Dow Jones Index Rises Ahead Of Fed Minutes; Nvidia Hits New High (Live Coverage)

Merck Plots $10 Billion Takeover Of COPD Drugmaker Verona Pharma

Investor's Business Daily

7 days ago

Merck Plots $10 Billion Takeover Of COPD Drugmaker Verona Pharma

UBS Affirms Merck & Co’s (MRK) ‘Buy’ Rating on HPV Vaccine Prospects

Insider Monkey

7 days ago

UBS Affirms Merck & Co’s (MRK) ‘Buy’ Rating on HPV Vaccine Prospects

MT Newswires

7 days ago

Traders Eye Fed Minutes as US Equity Futures Post Narrow Gains Pre-Bell

MT Newswires

7 days ago

Sector Update: Consumer

Merck Strikes $10 Billion Deal to Buy Verona Pharma

MT Newswires

7 days ago

Merck Strikes $10 Billion Deal to Buy Verona Pharma

Trump Unleashes Tariff Tsunami: Copper at 50%, Pharma Faces 200% -- Markets Rattle

GuruFocus.com

7 days ago

Trump Unleashes Tariff Tsunami: Copper at 50%, Pharma Faces 200% -- Markets Rattle

Dow Jones Futures Rise Amid Trump Tariff News; Elon Musk Tells Tesla Bull To 'Shut Up'

Investor's Business Daily

7 days ago

Dow Jones Futures Rise Amid Trump Tariff News; Elon Musk Tells Tesla Bull To 'Shut Up'

Impactivize: Shareholders of 30 Companies Worth $13 Trillion Vote Overwhelmingly to Defeat Anti-DEI Proposals

PR Newswire

8 days ago

Impactivize: Shareholders of 30 Companies Worth $13 Trillion Vote Overwhelmingly to Defeat Anti-DEI Proposals

MT Newswires

8 days ago

Certara Expands Clinical Technology Collaboration With Merck

Certara Announces Expansion of Clinical Technology Collaboration with Merck

GlobeNewswire

8 days ago

Certara Announces Expansion of Clinical Technology Collaboration with Merck

Merck to Present New Data Highlighting Research Advancements Across its HIV Prevention and Treatment Pipeline at IAS 2025

Business Wire

8 days ago

Merck to Present New Data Highlighting Research Advancements Across its HIV Prevention and Treatment Pipeline at IAS 2025

Analysis: 'Trump Effect' website takes credit for US investment made under Biden

Reuters

8 days ago

Analysis: 'Trump Effect' website takes credit for US investment made under Biden

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs

CNW Group

9 days ago

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs

Exelixis Surges 35.2% in Three Months: Buy or Sell the Stock?

Zacks

9 days ago

Exelixis Surges 35.2% in Three Months: Buy or Sell the Stock?

SMMT Stock Gains on Rumored Licensing Talks With AstraZeneca

Zacks

9 days ago

SMMT Stock Gains on Rumored Licensing Talks With AstraZeneca

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs

CNW Group

9 days ago

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs

mRNA Cancer Vaccines Clinical Trials & Future Market Outlook 2025: Personalized mRNA Cancer Vaccines Revolutionize Oncology with Neoantigen-Driven Immunotherapy

GlobeNewswire

9 days ago

mRNA Cancer Vaccines Clinical Trials & Future Market Outlook 2025: Personalized mRNA Cancer Vaccines Revolutionize Oncology with Neoantigen-Driven Immunotherapy

FDA Grants Priority Review for Merck & Co’s (MRK) WINREVAIR

Insider Monkey

10 days ago

FDA Grants Priority Review for Merck & Co’s (MRK) WINREVAIR

Merck & Co (MRK) Announces the Approval of ENFLONSIA

Insider Monkey

10 days ago

Merck & Co (MRK) Announces the Approval of ENFLONSIA

Top Dividend Stocks To Consider In July 2025

Simply Wall St.

11 days ago

Top Dividend Stocks To Consider In July 2025

Will Novo Nordisk's Rare Disease Bets Reduce GLP-1 Reliance?

Zacks

12 days ago

Will Novo Nordisk's Rare Disease Bets Reduce GLP-1 Reliance?

Sodium Perborate Market worth $184.0 million in 2030, at 3.7%, says MarketsandMarkets™

GlobeNewswire

12 days ago

Sodium Perborate Market worth $184.0 million in 2030, at 3.7%, says MarketsandMarkets™

TD Cowen Maintains Hold Rating on Merck After Enflonsia Vaccine Update

Insider Monkey

12 days ago

TD Cowen Maintains Hold Rating on Merck After Enflonsia Vaccine Update

Merck (MRK) Stock Slides as Market Rises: Facts to Know Before You Trade

Zacks

12 days ago

Merck (MRK) Stock Slides as Market Rises: Facts to Know Before You Trade

Will The Decline in Legacy Drugs Pull Down BMY's Top Line?

Zacks

13 days ago

Will The Decline in Legacy Drugs Pull Down BMY's Top Line?

MRK Pins Hopes on New PAH Drug Winrevair Amid Looming Keytruda LOE

Zacks

13 days ago

MRK Pins Hopes on New PAH Drug Winrevair Amid Looming Keytruda LOE

Here's How Lilly's Non-Obesity Drugs are Contributing to Sales Growth

Zacks

13 days ago

Here's How Lilly's Non-Obesity Drugs are Contributing to Sales Growth

Merck & Co. (MRK) Announces that US FDA Approves ENFLONSIA™ For Preventing RSV Lower Respiratory Tract Disease

Insider Monkey

13 days ago

Merck & Co. (MRK) Announces that US FDA Approves ENFLONSIA™ For Preventing RSV Lower Respiratory Tract Disease

Merck's Drug Slashes PAH Risk by 76%--FDA Fast-Tracks Game-Changer

GuruFocus.com

13 days ago

Merck's Drug Slashes PAH Risk by 76%--FDA Fast-Tracks Game-Changer

MT Newswires

13 days ago

Merck's HPV Vaccine Gardasil Remains Key Driver Ahead of Q2 Results, UBS Says

Merck (NYSE:MRK) Gains FDA Priority Review For WINREVAIR PAH Treatment sBLA

Simply Wall St.

13 days ago

Merck (NYSE:MRK) Gains FDA Priority Review For WINREVAIR PAH Treatment sBLA

What's Fueling Tempus AI's Explosive Sales Growth?

Zacks

14 days ago

What's Fueling Tempus AI's Explosive Sales Growth?

MT Newswires

14 days ago

Merck Says FDA Granted Priority Review to New Supplemental Biologics License Application for Winrevair

Merck concludes SpringWorks acquisition for $3.4bn

Pharmaceutical Technology

14 days ago

Merck concludes SpringWorks acquisition for $3.4bn

FDA Grants Priority Review for WINREVAIR™ (sotatercept-csrk) to Update Label Based on Results From ZENITH Trial

Business Wire

14 days ago

FDA Grants Priority Review for WINREVAIR™ (sotatercept-csrk) to Update Label Based on Results From ZENITH Trial

Can China sustain a surge in oncology drug innovation?

Pharma Voice

14 days ago

Can China sustain a surge in oncology drug innovation?

Summit Therapeutics (SMMT) Rated Buy on Ivonescimab’s Cancer-Fighting Potential

Insider Monkey

14 days ago

Summit Therapeutics (SMMT) Rated Buy on Ivonescimab’s Cancer-Fighting Potential

Trading Rotation Kicks Off 2nd Half of 2025

Zacks

14 days ago

Trading Rotation Kicks Off 2nd Half of 2025

Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report?

Zacks

14 days ago

Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report?

Merck to Hold Second-Quarter 2025 Sales and Earnings Conference Call July 29

Business Wire

15 days ago

Merck to Hold Second-Quarter 2025 Sales and Earnings Conference Call July 29

BMY Loses 16.3% YTD: Should You Buy, Sell or Hold the Stock?

Zacks

16 days ago

BMY Loses 16.3% YTD: Should You Buy, Sell or Hold the Stock?

Investing.com

16 days ago

Gilead extends gains after Supreme Court upheld an Obamacare provision

Merck’s (MRK) WINREVAIR Shows Strong Results in HYPERION Trial

Insider Monkey

18 days ago

Merck’s (MRK) WINREVAIR Shows Strong Results in HYPERION Trial

Should You Count on MRK for Steady Passive Income?

Insider Monkey

18 days ago

Should You Count on MRK for Steady Passive Income?

Cancer Vaccine (Preventative, Therapeutic) Market Research 2025 with Analyst Recommendations-Leveraging AI and Bioinformatics for Precision Development / Pursue Fast-Track and Orphan Drug Designations

GlobeNewswire

19 days ago

Cancer Vaccine (Preventative, Therapeutic) Market Research 2025 with Analyst Recommendations-Leveraging AI and Bioinformatics for Precision Development / Pursue Fast-Track and Orphan Drug Designations

Tempus AI's Data Business Keeps Scaling Up: Can the Growth Pace Last?

Zacks

19 days ago

Tempus AI's Data Business Keeps Scaling Up: Can the Growth Pace Last?

Merck (MRK) Stock Falls Amid Market Uptick: What Investors Need to Know

Zacks

19 days ago

Merck (MRK) Stock Falls Amid Market Uptick: What Investors Need to Know

MT Newswires

19 days ago

Merck Says US CDC Committee Recommends Enflonsia in Infants As RSV Preventive Option

The Anti-Vax Movement Solidifies Control of the CDC’s Vaccine Committee

Barrons.com

19 days ago

The Anti-Vax Movement Solidifies Control of the CDC’s Vaccine Committee

ACIP Recommends Use of Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season

Business Wire

19 days ago

ACIP Recommends Use of Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season

Will MRK's Growing Pipeline Help Navigate the Looming Keytruda LOE?

Zacks

20 days ago

Will MRK's Growing Pipeline Help Navigate the Looming Keytruda LOE?

Europe Proteomics Research Report 2025: Market Insights, Competitive Landscape and Forecasts 2024-2034 Featuring Biognosys, DiaSorin, Merck, Oxford Expression Technologies

GlobeNewswire

20 days ago

Europe Proteomics Research Report 2025: Market Insights, Competitive Landscape and Forecasts 2024-2034 Featuring Biognosys, DiaSorin, Merck, Oxford Expression Technologies

2 Stocks Too Cheap to Ignore at These Prices

Motley Fool

20 days ago

2 Stocks Too Cheap to Ignore at These Prices

Stifel Downgrades Zoetis (ZTS) Stock, Reduces PT

Insider Monkey

20 days ago

Stifel Downgrades Zoetis (ZTS) Stock, Reduces PT

Will New Drugs Enable BMY to Offset the Impact of Generic Competition?

Zacks

21 days ago

Will New Drugs Enable BMY to Offset the Impact of Generic Competition?

Merck Moves Past 50-Day Average: How to Play MRK Stock Now

Zacks

21 days ago

Merck Moves Past 50-Day Average: How to Play MRK Stock Now

Jefferies Maintains a Buy Rating on Merck & Co. (MRK), Keeps the PT Unchanged

Insider Monkey

21 days ago

Jefferies Maintains a Buy Rating on Merck & Co. (MRK), Keeps the PT Unchanged

2 Cash-Producing Stocks for Long-Term Investors and 1 to Think Twice About

StockStory

21 days ago

2 Cash-Producing Stocks for Long-Term Investors and 1 to Think Twice About

Jefferies Reaffirms Merck (MRK) ‘Buy’ Rating on Gardasil Dosing Stability

Insider Monkey

21 days ago

Jefferies Reaffirms Merck (MRK) ‘Buy’ Rating on Gardasil Dosing Stability

MRK's Winrevair Phase III Study in Newly Diagnosed PAH Meets Goal

Zacks

21 days ago

MRK's Winrevair Phase III Study in Newly Diagnosed PAH Meets Goal

Pfizer to Face Several Headwinds: Can It Successfully Navigate Them?

Zacks

21 days ago

Pfizer to Face Several Headwinds: Can It Successfully Navigate Them?

Sanofi Trades Below 50 & 200-Day Moving Averages: Time to Buy the Dip?

Zacks

22 days ago

Sanofi Trades Below 50 & 200-Day Moving Averages: Time to Buy the Dip?

EXEL Stock Rises on Positive Data From Colorectal Cancer Study

Zacks

22 days ago

EXEL Stock Rises on Positive Data From Colorectal Cancer Study

Share on Social Networks: